Back to search
FDAFDA · Food and drugs·Recall number D-0923-2023

Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10

Published July 26, 2023 · Recall initiated: June 21, 2023

Summary

FDA records drug Class II recall D-0923-2023, published July 26, 2023 and initiated June 21, 2023. Recalling firm: Dr Reddy's Laboratories Limited; Status: Ongoing; Reported quantity: 17,548 1000-countbottles; Lot: Lot: T2100585, T2100586, T2100587, Exp 12/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.

Get an email if TIZANIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TIZANIDINE
Manufacturer
Dr Reddy's Laboratories Limited
Distributor
Nationwide in the USA
UPC
0355111180104
Lot
Lot: T2100585, T2100586, T2100587, Exp 12/2023
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10 recalled?

Yes. FDA published recall D-0923-2023 on July 26, 2023. Reported hazard: Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.

What should I do if I have this product?

Stop using or selling the product and check the official FDA notice (D-0923-2023) for return or repair instructions.

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TIZANIDINE. UPC: 0355111180104.